Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Review today’s 30-year mortgage rate chart to compare trends and identify favorable rates across lenders.
23,821 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Grandparents are increasingly using a dividend-focused plan to fund college costs, aiming to preserve principal while...
A retiree with a $600,000 IRA defers claiming Social Security to age 70 to secure the 8% yearly boost. The strategy, ...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
The latest inflation report out shows retirees still face rising essentials even as COLA gains ease. Here's what that...
Investors are weighing Plug Power's turnaround against hydrogen hype. This guide breaks down the signals, risks, and ...
Dell Technologies crushed estimates with AI-driven demand for servers, sending shares higher after hours and promptin...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...
Two retail giants deliver contrasting strategies that still fuel gains for both. This analysis breaks down which play...
Beijing’s June trade data show a hefty export push that masks weak domestic demand, creating a controversial escape v...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
Looking to invest with a decade-long horizon? Here are three tech stocks to buy and hold, backed by strong moats, cas...